HELSENORGE
Four employees in the ex vivo facility. Photo
Mohn Research Centre for

Regenerative Medicine

In Mohn Research Centre for Regenerative Medicine (MRCRM), we aim to develop new cell-based therapies to repair or replace - to regenerate - tissues and cells damaged by disease or injury. Our research focus spans from biomedical to clinical research and clinical trials within the field of regenerative medicine, and our long-term aim is to offer patients new state-of-the-art therapies.

The goal of the Mohn Research Centre for
Logo. MRCRM. Mohn Research Centre for Regenerative Medicine.
Regenerative Medicine (MRCRM) is to support and strengthen the research environment within regenerative medicine in Bergen, with a particular focus on translating basic research into clinical 
st​udies that, in turn, will benefit the patients.

​We envision the Centre as an umbrella for the scientific community within this research area, providing a common hub where new research collaborations and ideas can evolve and take the field to the next level. We organize events​​ for the community regularly.

The Centre is a strategic initiative from Haukeland University Hospital at Helse Bergen Health Trust and the Faculty of Medicine at the University of Bergen, financed by Trond Mohn Foundation for five years. MRCRM builds on an active research environment and the newly established Ex vivo facility at the Laboratory building at Haukeland. This labo​ratory is a high-grade cleanroom facility operating under Good Manufacturing Practice (GMP) and will manufacture the cells for clinical trials affiliated with the Centre.​ 

The​ initial research projects affiliated to the Centre, and recruited through a generous grant by the Trond Mohn Foundation are presented below. 

Ou​r ob​​​​​j​e​​ctives

The objectives of the MRCRM are to coordinate groundbreaking fundamental research, and give patients access to state-of-the-art therapies, initially in clinical trials but later as established advanced, personalized treatment, see below. We will achieve this by:

  • ​Being the hub for the scientific community

  • Supporting and promoting fundamental and translational stem cell research

  • Enabling clinical trials with advanced therapy medicinal products (ATMPs) based on tissues and cells, employing the new GMP laboratory at Haukeland

  • Assisting in steering through the approval process by the Norwegian Medicinal Agency

  • Implementing novel therapies using ATMPs


Events

​Read more about our events and the MRCRM seminar series here.

In​​​fra​s​tructure

Read more about the new clean-room cell production laboratory called the Ex vivo facility.

Abou​t​​​ ​M​​RCRM

In August 2021, the Helse Bergen Health Trust and the University of Bergen established the Mohn Research Centre for Regenerative Medicine. Four research projects, recruited through grants from the Trond Mohn Foundation, comprise the initial scientific foundation of the Centre. 

The Trond Mohn Foundation has generously supported the initiative with 30 MNOK, and the host institutions have contributed with in total 60 MNOK. The Helse Bergen Health Trust has also invested a considerable amount in the new “Ex Vivo” cell production facility, which will be operable at Haukeland University Hospital by the end of 2022. 

The administrative unit of the Centre is located at the Department of Immunology and Transfusion Medicine in the Laboratory Building at Haukeland University Hospital. Still, our research is spread to dedicated laboratories and buildings around Bergen. Thus, so far this is a centre “without walls”. ​

The MRCRM Team

The appointed centre leader is Professor and MD Einar K. Kristoffersen, Head of the Department of Immunology and Transfusion Medicine at Haukeland University Hospital. He chairs the MRCRM Management group​, which meets monthly to discuss strategic and practical issues. 

The MRCRM Steering Group is chaired by the Helse Bergen deputy CEO Clara Gjesdal, and consists of representatives from the Helse Bergen Health Trust, the University of Bergen and the Trond Mohn Foundation. 

An international Scientific Advisory Board ​(SAB) has been established and consists of representatives with high compentency on cell therapy and research centre development. The role of the SAB ​is to support and evaluate the Centre.


​Join us!

​Are you working with regenerative medicine? Join the Centre!

Mohn Research Centre for Regenerative Medicine is an umbrella for the entire research community in Bergen and Western Norway, and we are planning seminar series​ and educational events. 

If you would like to be informed about MRCRM-related activities and upcoming events, send an e-mail to: ​MRCRM@helse-bergen.no​ or see contact information below​. ​



Logoer: Trond Mohn Foundation, Universitetet i Bergen, Haukeland University Hospital

​​​The Mohn Research Centre for Regenerative Medicine is supported by the Trond Mohn Foundation, University of Bergen, and Haukeland University Hospital.

News

Contact information

E-mail: MRCRM@helse-bergen.no

Elise Aasebø (coordinator)
Department of Immunology and Transfusion
Haukeland University Hospital

E-mail: elise.aasebo@helse-bergen.no
Phone: 55 97 30 45

Einar Klæbo Kristoffersen (Centre Leader)
Head of Department, Professor II
Department of Immunology and Transfusion
Haukeland University Hospital

E-mail: einar.kleboe.kristoffersen@helse-bergen.no
Phone: 55 97 46 83  /  48 17 12 72


​​Did you find what you were looking for?